Blindness in a 25-Year Follow-up of a Population-Based Cohort of Danish Type 1 Diabetic Patients

Ophthalmology

Volumn 116, Issue 11, 2009, Pages 2170-2174

  Grauslund, Jakob ^a   Green, Anders ^a   Sjølie, Anne Katrin ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; BLINDNESS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; DISEASE DURATION; EYE EXAMINATION; FEMALE; FOLLOW UP; GROUPS BY AGE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; PROTEINURIA; RETINA MACULOPATHY; RETINOPATHY; RISK FACTOR; SEX DIFFERENCE; SMOKING HABIT; SYSTOLIC BLOOD PRESSURE; VISUAL ACUITY;

ADULT; AGE DISTRIBUTION; BLINDNESS; BLOOD PRESSURE; DENMARK; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; SMOKING; VISUAL ACUITY;

EID: 70350566640     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2009.04.043     Document Type: Article

References (27)

1. Klein R., and Klein B.E. Vision disorders in diabetes. National Diabetes Data Group. Diabetes in America. 2nd ed. (1995), NIDDKD, National Institutes of Health, Bethesda, MD 293-338. http://diabetes.niddk.nih.gov/dm/pubs/america/pdf/chapter14.pdf NIH Publication no. 95-1468. Accessed April 22, 2009
2. Sjølie A.K., and Green A. Blindness in insulin-treated diabetic patients with age at onset less than 30 years. J Chronic Dis 40 (1987) 215-220
3. Moss S.E., Klein R., and Klein B.E. The incidence of vision loss in a diabetic population. Ophthalmology 95 (1988) 1340-1348
4. Moss S.E., Klein R., and Klein B.E. Ten-year incidence of visual loss in a diabetic population. Ophthalmology 101 (1994) 1061-1070
5. Nielsen N.V. Diabetic retinopathy I. The course of retinopathy in insulin-treated diabetics: a one year epidemiological cohort study of diabetes mellitus. The Island of Falster, Denmark. Acta Ophthalmol (Copenh) 62 (1984) 256-265
6. Rand L.I., Prud'homme G.J., Ederer F., Canner P.L., and Diabetic Retinopathy Study Research Group. Factors influencing the development of visual loss in advanced diabetic retinopathy: Diabetic Retinopathy Study (DRS) report no. 10. Invest Ophthalmol Vis Sci 26 (1985) 983-991
7. Moss S.E., Klein R., and Klein B.E. The 14-year incidence of visual loss in a diabetic population. Ophthalmology 105 (1998) 998-1003
8. Agardh E., Agardh C.D., and Hansson-Lundblad C. The five-year incidence of blindness after introducing a screening programme for early detection of treatable diabetic retinopathy. Diabet Med 10 (1993) 555-559
9. Dwyer M.S., Melton III L.J., Ballard D.J., et al. Incidence of diabetic retinopathy and blindness: a population-based study in Rochester, Minnesota. Diabetes Care 8 (1985) 316-322
10. Caird F.I., Burditt A.F., and Draper G.J. Diabetic retinopathy: a further study of prognosis for vision. Diabetes 17 (1968) 121-123
11. Deckert T., Simonsen S.E., and Poulsen J.E. Prognosis of proliferative retinopathy in juvenile diabetics. Diabetes 16 (1967) 728-733
12. Roy M.S., and Skurnick J. Six-year incidence of visual loss in African Americans with type 1 diabetes mellitus: the New Jersey 725. Arch Ophthalmol 125 (2007) 1061-1067
13. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329 (1993) 977-986
14. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 103 (1985) 1796-1806
15. Diabetic Retinopathy Study Research Group. Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol 81 (1976) 383-396
16. Green A., Hauge M., Holm N.V., and Rasch L.L. Epidemiological studies of diabetes mellitus in Denmark. II. A prevalence study based on insulin prescriptions. Diabetologia 20 (1981) 468-470
17. Sjolie A.K. Ocular complications in insulin treated diabetes mellitus: an epidemiological study. Acta Ophthalmol Suppl 172 (1985) 1-77
18. Grauslund J., Green A., and Sjolie A.K. Proliferative retinopathy and proteinuria predict mortality rate in type 1 diabetic patients from Fyn County, Denmark. Diabetologia 51 (2008) 583-588
19. Grey R.H., Burns-Cox C.J., and Hughes A. Blind and partial sight registration in Avon. Br J Ophthalmol 73 (1989) 88-94
20. Kahn H.A., and Hiller R. Blindness caused by diabetic retinopathy. Am J Ophthalmol 78 (1974) 58-67
21. Klein R., Klein B.E., and Moss S.E. Visual impairment in diabetes. Ophthalmology 91 (1984) 1-9
22. Icks A., Trautner C., Haastert B., et al. Blindness due to diabetes: population-based age- and sex-specific incidence rates. Diabet Med 14 (1997) 571-575
23. Roy M.S. Diabetic retinopathy in African Americans with type 1 diabetes: the New Jersey 725: I. Methodology, population, frequency of retinopathy, and visual impairment. Arch Ophthalmol 118 (2000) 97-104
24. Sjolie A.K., Stephenson J., Aldington S., et al. Retinopathy and vision loss in insulin-dependent diabetes in Europe: the EURODIAB IDDM Complications Study. Ophthalmology 104 (1997) 252-260
25. Trautner C., Icks A., Haastert B., et al. Diabetes as a predictor of mortality in a cohort of blind subjects. Int J Epidemiol 25 (1996) 1038-1043
26. Trautner C., Icks A., Haastert B., et al. Incidence of blindness in relation to diabetes: a population-based study. Diabetes Care 20 (1997) 1147-1153
27. From the Centers for Disease Control and Prevention. Blindness caused by diabetes-Massachusetts, 1987-1994. JAMA 276 (1996) 1865-1866